58 related articles for article (PubMed ID: 20048135)
1. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.
Aggarwal BB; Gupta SC; Kim JH
Blood; 2012 Jan; 119(3):651-65. PubMed ID: 22053109
[TBL] [Abstract][Full Text] [Related]
2. Serotonin 5-HT2A receptor activation blocks TNF-α mediated inflammation in vivo.
Nau F; Yu B; Martin D; Nichols CD
PLoS One; 2013; 8(10):e75426. PubMed ID: 24098382
[TBL] [Abstract][Full Text] [Related]
3. Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication.
Nery Neto JAO; Yariwake VY; Câmara NOS; Andrade-Oliveira V
Front Pharmacol; 2023; 14():1248757. PubMed ID: 37927592
[TBL] [Abstract][Full Text] [Related]
4. Tumor Necrosis Factor Alpha and the Gastrointestinal Epithelium: Implications for the Gut-Brain Axis and Hypertension.
Souders CL; Zubcevic J; Martyniuk CJ
Cell Mol Neurobiol; 2022 Mar; 42(2):419-437. PubMed ID: 33594519
[TBL] [Abstract][Full Text] [Related]
5. Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities.
Izzi B; Tirozzi A; Cerletti C; Donati MB; de Gaetano G; Hoylaerts MF; Iacoviello L; Gialluisi A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233416
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic responses to
Myles IA; Castillo CR; Barbian KD; Kanakabandi K; Virtaneva K; Fitzmeyer E; Paneru M; Otaizo-Carrasquero F; Myers TG; Markowitz TE; Moore IN; Liu X; Ferrer M; Sakamachi Y; Garantziotis S; Swamydas M; Lionakis MS; Anderson ED; Earland NJ; Ganesan S; Sun AA; Bergerson JRE; Silverman RA; Petersen M; Martens CA; Datta SK
Sci Transl Med; 2020 Sep; 12(560):. PubMed ID: 32908007
[TBL] [Abstract][Full Text] [Related]
7. Conformational states of TNFR1 as a molecular switch for receptor function.
Lo CH; Huber EC; Sachs JN
Protein Sci; 2020 Jun; 29(6):1401-1415. PubMed ID: 31960514
[TBL] [Abstract][Full Text] [Related]
8. Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine.
Tariq Z; Board N; Eftimiades A; Ibrahim R
SAGE Open Med Case Rep; 2019; 7():2050313X19847804. PubMed ID: 31105954
[TBL] [Abstract][Full Text] [Related]
9. A New Venue of TNF Targeting.
Steeland S; Libert C; Vandenbroucke RE
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751683
[TBL] [Abstract][Full Text] [Related]
10. The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1.
Qin L; Zhao D; Xu J; Ren X; Terwilliger EF; Parangi S; Lawler J; Dvorak HF; Zeng H
Blood; 2013 Mar; 121(11):2154-64. PubMed ID: 23315169
[TBL] [Abstract][Full Text] [Related]
11. The immunology of blood: connecting the dots at the neurovascular interface.
Akassoglou K
Nat Immunol; 2020 Jul; 21(7):710-712. PubMed ID: 32577008
[No Abstract] [Full Text] [Related]
12. How do tumor necrosis factor receptors work?
Bazzoni F; Beutler B
J Inflamm; 1995; 45(4):221-38. PubMed ID: 8867667
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor-mediated signaling pathways.
Heller RA; Krönke M
J Cell Biol; 1994 Jul; 126(1):5-9. PubMed ID: 8027185
[No Abstract] [Full Text] [Related]
14. Wishing away inflammation? New links between serotonin and TNF signaling.
Pelletier M; Siegel RM
Mol Interv; 2009 Dec; 9(6):299-301. PubMed ID: 20048135
[TBL] [Abstract][Full Text] [Related]
15. A man of vision and the discovery of tumor necrosis factor.
Carswell-Richards EA; Williamson BD
Cancer Immun; 2012; 12():4. PubMed ID: 22896749
[No Abstract] [Full Text] [Related]
16. Attracting Attention: Discovery of IL-8/CXCL8 and the Birth of the Chemokine Field.
Moore BB; Kunkel SL
J Immunol; 2019 Jan; 202(1):3-4. PubMed ID: 30587567
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
